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ABSTRACT PAGE
The bacterial pathogen Helicobacter pylori exclusively colonizes the human gastric 
epithelium, causing chronic inflammation which leads to gastritis in most of those who are 
infected. The long-term presence of H. pylori also promotes the development of more 
severe conditions such as ulcers, and is a significant risk factor for gastric cancers such as 
adenocarcinoma. In addition to being an important human pathogen, H. pylori is also an 
ideal system for basic study of bacterial gene regulation. This species controls expression 
of a wide array of target genes in response to environmental signals using only three two- 
component signal transduction (TCST) systems: ArsRS, FlgRS, and CrdRS. Evidence of 
co-regulation of some genes by more than one of these pathways suggests that H. pylori 
compensates for this apparent deficiency in regulatory ability through a complex network of 
cross-regulation interactions. The acetone carboxylase operon, acxABC, may be regulated 
by all three of these signal transduction pathways. This extensive regulation of acetone 
metabolism suggests that this capability is important for H. pylori's ability to infect and 
survive in the gastric mucosa, and may reveal promising targets for drug development. In 
order to characterize the activity of transcription factors that regulate this operon, I have 
cloned, expressed, and purified the response regulator component of each of H. pylori's 
TCST systems along with the orphan response regulator HP1021. Electrophoretic mobility 
shift assays (EMSAs) were performed with these response regulators and DNA probes 
amplified from the putative upstream regulatory region of acxABC. Results confirm the 
direct binding of ArsR and HP1021 to the acxA promoter observed in previous studies, and 
suggest that as many as four ArsR binding sites may be involved in regulation of acxABC. 
Results also suggest that regulation of acxA by CrdR is direct and involves multiple binding 
sites or conformations. FlgR bound to the acxA promoter region in a nonspecific manner, 
suggesting that FlgR must interact with another DNA-binding protein to activate acxA 
transcription, or that regulation of acxA by FlgR is indirect. These results establish acxA as 
a model target gene for future study of how H. pylori can finely modulate transcription of a 
single operon via multiple direct regulatory systems and mechanisms. Furthermore, the 
optimization of methods and protocols in the course of this study has made additional tools 
for investigation of TCST networking available to our research group.
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Introduction
Pathogenicity of Helicobacter pylori
Helicobacter pylori was first identified in 1982 as a gram negative microaerophilic 
helical bacterium endemic to the human gastric mucosa, and belongs to the class e- 
proteobacteria. Soon after this discovery, a strong correlation was established between 
infection with this pathogen and the presence of gastric and duodenal ulcers, which were 
previously thought to be caused by stress or diet (1). These ulcers may now be treated with a 
high rate of success using antibiotics to eradicate the infection along with additional 
medications to reduce pain and inflammation (2). However, H. pylori is still highly prevalent: 
approximately 50% of the world population and 30% of people in the United States are 
currently H. pylori-positive. Infection rates vary with geographical location, race, gender and 
socioeconomic status (3). Most of those infected will develop gastritis at some point in their 
lives, but the chronic inflammatory response to infection can also lead to more severe 
symptoms and conditions such as peptic ulcer disease (including gastric and duodenal ulcers, 
which occur in -10%  of those infected), non-Hodgkins lymphoma, and gastric cancers such 
as adenocarcinoma (4). In 2000, gastric adenocarcinoma was the fourteenth most common 
cancer worldwide, with H. pylori infection as its second-strongest risk factor after family 
history (5).
Total genome sequences have been published for multiple strains of H. pylori,
including the pathogenic strains J99 and 26695 (6). Some strains are more virulent in humans
than others. One genetic factor that increases virulence is the cytotoxin associated antigen
pathogenicity island (cag PAI). The cag PAI is a 40kB region o f DNA including genes
homologous to a known type IV secretion system that moves bacterial protein and DNA into
host cells, leading to tumorigenesis in the host (7). H. pylori strains isolated from patients
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without severe gastric disease frequently lack the cag PAI, while infection with cag PAI- 
positive strains has been shown to increase risk of gastric adenocarcinoma relative to risk 
faced by uninfected individuals and those infected with a strain lacking this pathogenicity 
island (4). Additionally, there is significant genetic variation between H. pylori strains that 
goes beyond the presence or absence of the cag PAI. For example, while the average genome 
size is -1 .7  Mb, this can vary between strains by more than 24 kb in addition to the 40 kb 
pathogenicity island (6). The H. pylori strains used in the research described in this thesis 
were 26695 and J99, both of which possess the cag PAI and were isolated from patients with 
H. />y/0 n-associated gastric disease. Since genome content is variable among strains, raising 
the possibility that some genetic regulatory mechanisms may not be conserved, experiments 
with known pathogenic strains for which the full-genome sequence is already available 
should yield the most medically relevant information.
The purpose o f the research described in this thesis is to broaden understanding of 
how H. pylori alters its global gene expression in response to environmental changes. Much 
work has been done regarding the mechanisms of virulence employed by H. pylori once an 
infection has been established, but little is known about the genetic mechanisms that regulate 
the process of infection, host colonization, and ability to survive in a constantly changing, 
often harsh environment. In addition to contributing to general understanding of bacterial 
gene regulation, knowledge of H. pylori survival mechanisms could facilitate the 
development of targeted drugs, which could address the growing problem of antibiotic 
resistance. The FDA-approved eradication protocols recommended for H. pylori as of 2006 
all included at least two antibiotics, to decrease the possibility o f treatment failure due to 
resistance. Simultaneous treatment with three antibiotics is becoming increasingly common 
(2). Treatment with broad-spectrum antibiotics such as amoxicillin, which is called for by
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four of the FDA’s eight approved eradication protocols, carries its own risks for patients 
whether or not they are infected with antibiotic-resistant H. pylori. In addition to eradicating 
pathogens, antibiotics affect the symbiotic and commensal flora of the gut and in doing so put 
the patient at risk for secondary infections. Antibacterial drugs designed to disable the 
metabolic pathways o f pathogens in a species-specific or strain-specific manner represent a 
promising solution. A complete map of the regulatory pathways of Helicobacter pylori would 
reveal a wider range of options for drug targets.
Two-Component Signal Transduction
Two-component signal transduction (TCST), also called histidine-aspartate 
phosphotransfer, is the most prevalent means by which bacteria detect and respond to 
environmental signals by inducing or repressing gene expression. (Environmental signals 
may be ligands such as metal ions or nutrients, or they may be conditions such as osmolarity 
or temperature.) TCST systems typically consist of a transmembrane histidine kinase sensor 
protein and a cytoplasmic DNA-binding response regulator protein. When the sensor detects 
an environmental signal, it autophosphorylates at a histidine residue. This phosphoryl group 
is then transferred to an aspartate residue in the N-terminal receiver domain of the response 
regulator, altering its regulatory activity (Figure 1). The response regulator is usually 
activated through a change in conformation that makes its C-terminal DNA-binding domain 
more readily available to bind its target sequence. Two-component system response 
regulators cannot autophosphorylate by cleaving ATP, but they can accept phosphate groups 
from small-molecule phosphodonors such as acetyl phosphate. In some systems where small- 
molecule phosphodonors are present in the cytosol in significant amounts, this can lead to a 
low baseline level of response regulator phosphorylation (8).
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Figure 1. A Typical Two-Component Signal Transduction System. A TCST system in which the 
response regulator is only active in gene regulation when phosphorylated is shown for the sake of 
simplicity. Other mechanisms are possible, including systems in which phosphorylation shifts the 
response regulator between two distinct functions, (a) The periplasmic domain of the sensor kinase 
senses an environmental signal, (b) The cytoplasmic domain of the sensor kinase autophophorylates at 
a histidine residue, (c) The phosphate group is transferred from the sensor kinase to an aspartate residue 
in the receiver domain of the response regulator, (d) The response regulator binds DNA and activates 
or represses transcription of its target gene(s). (e) The response regulator is dephosphorylated. DNA 
clipart © DragonArt Designs, 2010.
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Response regulators usually act directly on their target genes as transcription factors, 
but some multistep phosphorelay systems and TCST response regulators that interact with 
other transcription factors have been identified as well (8). While it is possible that some 
TCST systems are isolated and thus regulate one gene or set of genes each in response to one 
type of environmental signal, there is some evidence of interaction between systems (9). 
Overall, little is known about most bacteria TCST systems aside from the general model 
described above. According to a recent review, novel TCST systems can be reliably 
discovered by searching for amino acid sequence homology, but amino acid sequences 
cannot yet be used to make predictions about regulatory targets, environmental signals, or 
regulatory networks (8).
Two-component Signal Transduction and Pathogenicity
Complex Regulation of Virulence Factor Expression via TCST in the Bordetellae
Though regulation of virulence factors other than motility via two-component signal 
transduction has not yet been described in Helicobacter pylori, this type of regulatory 
mechanism takes a central role in the pathogenicity of several other bacterial species. 
Bordetella pertussis, an exclusive human pathogen and the causative agent of whooping 
cough, and Bordetella bronchiseptica, which can colonize and cause respiratory infections in 
most mammals, regulate expression of virulence factors in response to environmental 
conditions via the BvgAS two-component signal transduction system. BvgAS controls 
expression o f Bordetallae virulence factors including adhesins and secreted toxins by 
transitioning between at least three modes of global gene expression: Bvg+, Bvg1, and Bvg'. 
The Bvg+ phase can be induced by growth in the laboratory at 37°C, and is thought to be a 
response to the host environment. BvgS, a transmembrane sensor kinase, responds to this
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temperature (and possibly other host signals) by autophosphorylating and then transferring its 
phosphate groups to the response regulator BvgA. BvgA~P then activates transcription of 
the &vg-activated regulon, which includes virulence factors and the bvgAS operon itself. This 
positive feedback loop results in increased expression of the third member of this operon, 
bvgR. BvgR is a transcription factor that represses expression o f a distinct regulon referred to 
as the &vg-repressed genes (10). The 6vg-repressed genes o f B. pertussis are mostly of 
unknown function, but in B. bronchiseptica this regulon is known to include genes required 
for motility and survival of nutrient deprivation. Exposure of the sensor domain of BvgS to 
modulating signals, which include temperatures below 26°C and millimolar concentrations of 
MgS0 4  or nicotinic acid, causes the cells to move into the Bvg'phase. BvgS does not 
autophosphorylate in this phase, so transcription of the &vg-activated regulon is no longer up- 
regulated and transcription of the &vg-repressed regulon is free to occur. Bvg1, an 
intermediate phase, is characterized by high expression of adhesins, low expression of toxins, 
and the expression o f a set of highly immunogenic membrane proteins with homology to E. 
coli intimins (11). The Bvg+ phase appears to be optimized for infection and the Bvg'phase 
appears to be important for survival of B. bronchiseptica outside the host. (B . pertussis 
cannot survive for long outside the host, so the Bvg' phase may be vestigial in this species.) It 
has been suggested that the expression of putative intimins and genes that facilitate 
aggregation of B. pertussis cells during the Bvg1 phase makes this phase important for 
transmission of B. pertussis (12).
The transition of global gene expression between the Bvg+ and Bvg- states has been 
described as analogous to a rheostat as opposed to a simple two-pole switch (11). BvgA-P 
has a higher affinity for the promoters of some members of its regulon than others, resulting 
in increased sensitivity o f the expression levels of these genes to phosphorylation of BvgS.
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These are termed "early" promoters, and loss of activation by BvgA at these promoters 
requires higher environmental levels of modulating signals. Transcriptional activation of 
members of the BvgAS regulon with "late" promoters is less responsive to BvgS 
phosphorylation, but is more sensitive to modulation by environmental signals (10). This 
model of graded transcriptional control and multiple modes of global gene expression 
controlled by a single TCST system exemplifies the complexity o f function that may 
characterize the TCST systems of H. pylori.
TCST Networking and Virulence in the Salmonellae
Two-component signal transduction is also important for pathogenesis in the
Salmonellae, which cause enteric disease including typhoid fever. To establish a successful
infection, Salmonella enterica serovar Typhimurium must be able to survive phagocytosis by
a macrophage of neutrophil. S. enterica Typhimurium senses the phagosomal environment
via the PhoQ two-component signal transduction sensor kinase, which leads to
phosphorylation of the PhoP response regulator (13). PhoPAP activates transcription of the
pag  (PhoP-activated genes) regulon and represses expression o f the prg  (PhoP-repressed
genes) regulon. The pag  regulon includes a variety of outer membrane proteins and
lipopolysaccharide-modifying enzymes. Because the host innate immune response recognizes
the lipid A portion o f lipopolysaccharide (LPS), constant structural modification of this
virulence factor by the bacterium is necessary for evasion of the immune response.
Salmonellae also resist the immune system in part through the PhoP-activated expression of
genes that promote resistance to antimicrobial peptides produced by host cells. As in the case
of BvgA in Bordetellae described above, variations in the response by different members of
the pag  regulon to phosphorylation of PhoP is thought to be caused by differences in
regulatory sequence o f these target genes (14). When S. enterica Typhimurium is in the
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extracellular host environment, concentrations of Mg2+ and Ca2+ are higher than in the 
phagosome. PhoQ does not autophosphorylate in the presence of these cations, which leads 
to a decrease in the amount of PhoP~P present in the cell. These conditions promote 
transcription of the prg  regulon, which consists of genes required for epithelial cell invasion 
that are repressed by Pho~P (15). The PhoPQ TCST contributes to regulation of 
approximately 3% of the S. typhimurium genome (14).
Like the BvgAS TCST of the Bordetellae, the PhoPQ TCST is more complex than a 
switch between two gene expression patterns. Recent research has revealed extensive 
networking between PhoPQ and other TCST systems of the Salmonellae. Transcription of the 
pmrAB  operon, which encodes a TCST system required for expression o f genes involved in 
resistance to antimicrobial peptides, is activated by PhoP~P in response to phagocytosis. 
PmrA also activates transcription of the pmrAB  operon in a positive feedback loop (16). 
Additionally, there is evidence of protein-protein interaction between the RstB TCST sensor 
kinase and PhoQ that results in increased expression of the pag  regulon (17). The existence 
of at least two different types of interaction between TCST systems in a single species 
suggests that precise control of genes required for survival and virulence in response to 
changing environmental conditions may be achieved through extensive TCST networking. 
Like Salmonella, H. pylori encounters a wide range of environmental conditions during the 
infection and colonization process. The importance of TCST networking in control of the 
transition of S. enterica serovar Typhimurium from colonization to intracellular infection 
suggests that similar networking may be required during the infection process for H. pylori.
Two-component Signal Transduction in Helicobacter pylori
Helicobacter pylori is known to possess three two-component signal transduction
systems: CrdRS (copper resistance determinant), ArsRS (acid response system), and FlgRS
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(flagellum-based motility). This is a small number of TCST pathways compared with most 
bacteria, though not surprising as obligate pathogens like H. pylori tend to have relatively 
few genetic regulatory pathways dedicated to transduction of environmental signals (18). A 
possible explanation for this trend is that bacteria that are limited to colonization of a narrow 
range of environments (and in the case of H. pylori, one type of tissue in one host species) 
will experience less selective pressure to devote resources to environmental response 
compared with free-living organisms which may exist in much more variable conditions. 
Because of its relatively small number of TCST systems, H. pylori is an ideal model for the 
basic study of cross-regulation or networking among TCST networks (19). Through a series 
of experiments designed to detect protein/DNA interactions, I have begun to characterize the 
mechanisms for transcriptional regulation of the acetone carboxylase operon, which is a 
common target gene of multiple TCST response regulators in H. pylori.
The ArsRS Two-Component Signal Transduction System
ArsRS (HP0166 and HP0165 in Helicobacter pylori strain 26695) is currently the
best-characterized two-component signal transduction system of H. pylori. The histidine
kinase ArsS resides within the cytoplasmic membrane with domains in both the periplasm
and cytoplasm and autophosphorylates in response to pH values <5.0. ArsR (25.9 kDa,
predicted pi = 5.27) is a cytoplasmic response regulator consisting of a C-terminal DNA-
binding effector domain containing a helix-tum-helix motif, and an N-terminal receiver
domain with homology to known ATPases (20). This domain architecture is typical of
response regulators. Though a small part of the receiver domain of ArsR is homologous to a
common dimerization interface, ArsR is only known to exist as a monomer (21). Depending
on the position of the ArsR-binding site relative to the promoter of its target gene, ArsR or
ArsR-P can repress or activate transcription. Currently, no consensus sequence has been
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identified for ArsR binding sites. The major function of this TCST system is regulation of the 
acid acclimation response, including the activation of urease genes in response to 
acidification of the periplasm. Although H. pylori is a neutralophile, it must tolerate the 
highly acidic gastric environment during infection and colonization. One survival mechanism 
employed by H. pylori in acidic conditions is the creation o f a pH-neutral microenvironment 
through the expression o f urease and amidase enzymes, which catalyze ammonia production. 
ArsR, when phosphorylated in response to ArsS phosphorylation, directly activates 
transcription of these acid acclimation genes (22).
The regulatory function of ArsRS beyond its role in acid acclimation is not as 
thoroughly understood. Though both ArsR and ArsS are necessary for survival of H. pylori in 
both neutral and acidic environments, strains in which ArsR cannot be phosphorylated by 
ArsS can grow at neutral pH (23, 24). Additionally, unphosphorylated ArsR is still capable 
of binding DNA in vitro (24). These results suggest the existence of an essential 
phosphorylation-independent regulon for ArsR. There is also a subset of the ArsR regulon 
that requires phosphorylation of ArsR and is not deregulated in arsS- mutants; that is, 
expression levels o f these genes change in response to acid exposure by the same amounts in 
arsS- mutants as they do in wild-type H. pylori (19). This suggests at least one additional 
mechanism of ArsR phosphorylation beyond phosphotransfer from ArsS. A recent review of 
H. pylori regulatory networks contends that overlap between the FlgS regulon and the genes 
regulated by ArsR~P but not ArsS suggests that FlgS may also be able to mediate 
phosphorylation of ArsR (19). There is also overlap between the regulons of CrdRS (the 
TCST system that regulates transcription of copper resistance genes) and ArsRS in some H. 
pylori strains, suggesting cross-regulation between the metal homeostasis and acid 
acclimation regulatory networks (25).The transcription of the ArsRS operon itself is activated
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directly by the transcription factor Fur, which regulates intercellular iron homeostasis and 
contributes to the oxidative stress response, in response to increases in cytoplasmic iron 
concentrations (26).
The CrdRS Two-Component Signal Transduction System
The CrdRS operon includes the inner membrane-associated histidine kinase CrdS 
(HP 1364) and the cytoplasmic response regulator CrdR (HP 1365, 24.9 kDa, predicted pi = 
5.67). Based on its amino acid sequence, CrdR is composed o f an N-terminal receiver 
domain with an aspartic acid phosphorylation site and a C-terminal DNA-binding effector 
domain. CrdR and ArsR, though similar in domain architecture, have only 53% amino acid 
sequence homology (20).
The best-characterized function of CrsRS is its role in copper homeostasis. Though 
copper is a necessary cofactor for many essential metabolic processes in H. pylori, an excess 
of intracellular copper can cause DNA damage through oxidative stress. CrsRS activates 
expression of the copper resistance determinant CrdA in response to increases in 
environmental copper concentrations. Whether CrdS directly senses an increase in copper 
ions or another environmental signal indicative of this change has not been proven. When 
copper ions are introduced into an aqueous environment they cause the formation of reactive 
oxygen species via Fenton-like reactions (27). It is possible that CrdS, rather than being 
dedicated solely to copper homeostasis, is a global sensor of oxidative stress. CrsRS is also 
involved in the acid acclimation response in H. pylori strain J99, but not in strains 26695 and 
G27 (25, 28). This inter-strain difference in regulatory processes highlights the need to 
confirm experimental results in multiple strains of H. pylori.
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The FlgRS Two-Component Signal Transduction System
Flagellar-based motility is necessary for persistent colonization o f a host by H. pylori 
(29). The transcription of at least five operons encoding structural components of the flagella 
is under the control of a a 54 promoter and is activated by the response regulator FlgR 
(HP0703, 43.4 kDa, predicted pi = 6.31). Unlike some of its orthologs in similar species, H. 
pylori FlgR does not appear to possess a DNA-binding domain. In a study performed with 
FlgR from H. pylori strain 26695, FlgR was able to activate transcription of flagellar genes 
by interacting with either E. coli or H. pylori o54-RNA polymerase in the presence of minimal 
upstream regulatory sequence, suggesting that FlgR does not require an enhancer. Based on 
its amino acid sequence, H. pylori FlgR possesses an N-terminal receiver domain containing 
a potential dimerization interface, and a C-terminal ATPase domain o f the AAA+ 
superfamily similar to those of other o54-holoenzyme activators (30). (There is no 
experimental evidence that FlgR is able to autophosphorylate by cleaving ATP.)
FlgS (HP0244), the cognate histidine kinase of FlgR, is thought to localize to the 
cytoplasm based on its amino acid sequence. If so, FlgS would be the only cytoplasmic 
TCST sensor in H. pylori. FlgS is required by H. pylori strain 26695 for survival at pFl values 
<2.5 but not at pH values between 2.5 and 4.5, and a subset of the known FlgS regulon 
including genes involved in the acid acclimation response and the cag PAI gene cagA (which 
encodes a toxin secreted into host cells) is activated at low pH (31). It is possible that FlgS 
acts as a sensor of cytoplasmic acidification and regulates the acid acclimation response in 
concert with ArsRS (32). Though flgR- H. pylori mutants are non-motile, they are able to 
survive acidic conditions that flgS- mutants are not. This suggests that the contribution of
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FlgS to acid acclimation is unrelated to motility, and that FlgS may transmit its pH- 
responsive signal through another response regulator, potentially ArsR. The pH-independent 
subset of the FlgS regulon includes the flagellar regulon of FlgR and 11 other genes (31). 
Transcription of some o f these target genes is regulated in response to acid, but not by FlgS 
(6, 33). The signal or signals detected and transduced by FlgRS to activate transcription of 
this regulon have not yet been identified.
The Orphan Response Regulator HP1021
The orphan response regulator HP 1021 (35.2 kDa, predicted pi = 8.09) is essential 
for normal growth o f Helicobacter pylori: deletion of ORF hpl021 from the H. pylori strain 
26695 genome is either lethal or causes severely impeded growth (34). (The term “orphan” is 
used because although HP 1021 is structurally similar to other TCST response regulators, no 
cognate sensor kinase for HP 1021 has been identified.) HP 1021 activates transcription of the 
essential housekeeping genes nifS and nifU, which encode nitrogenases necessary for the 
assembly of iron-sulfur clusters and may account for the impaired growth of the hpl021- 
mutant (35). Whole-genome transcriptional profiling identified increased expression levels of 
28 genes and decreased expression levels of 51 genes in a hpl021-H . pylori mutant, 
suggesting that HP 1021 may be both a repressor and activator of transcription (35).
HP 1021 has been classified as a response regulator based on domain architecture.
The C-terminal DNA-binding domain of HP 1021 contains a helix-tum-helix motif but shows
no significant homology to any DNA-binding domain or domain superfamily in the NCBI
Conserved Domains database (20). The N-terminal receiver domain of HP 1021 has some
homology with the receiver domains of the other Helicobacter pylori response regulators, but
the aspartic acid at the consensus phosphorylation site is replaced in HP 1021 by serine. This
atypical serine residue does not appear to be necessary for the essential function of HP 1021,
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as H. pylori with amino acid substitutions at and on either side of this residue display a wild- 
type growth phenotype (36). There is no evidence that HP 1021 can be phosphorylated by 
either a histidine kinase or acetyl phosphate, and an alternate post-translation mechanism by 
which the activity o f HP 1021 could be modulated has not yet been identified. The 
transcription of HP 1021 is up-regulated in response to an acidic pH, though HP 1021 is not 
known to be included in either the ArsRS or FlgRS regulons (6, 37, 31). It is possible that 
HP 1021 itself is only regulated at the level of transcription. However, stringent regulation of 
HP 1021 may not be necessary for normal growth of H. pylori, as overexpression of HP 1021 
in H. pylori strain G27 had no detrimental effects on growth in vitro (38).
Two-Component Signal Transduction and Acetone Metabolism
Acetone, along with acetoacetate and 3-P-hydroxybutyrate, is produced in the 
mammalian liver during fatty acid metabolism and enters the bloodstream (39). Because the 
spontaneous decomposition of acetoacetate to acetone is accelerated at low pH, gastric 
tissues may be enriched in acetone in comparison to the rest of the body, conferring a 
survival advantage to gastric pathogens that can use acetone as a carbon source. Helicobacter 
pylori absorbs acetone from its host tissue and converts it to acetyl-CoA, which is essential 
for initiation of the Krebs cycle. The first step in this process is the conversion of acetone to 
acetoacetate, carried out by the enzyme acetone carboxylase. Though deletion of the acetone 
carboxylase operon (acxABC; HP0695-7 in H. pylori 26695) is not lethal for H. pylori, the 
presence of functional acetone carboxylase enhances the ability o f H. pylori to colonize and 
infect mice (40). Because mice do not experience H. pylori-induced gastric illness, any 
connection of acxABC  to virulence beyond colonization remains unknown. (H . pylori 
infection is usually exclusive to humans, but animal-acclimated strains can be created in the 
laboratory.)
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There is approximately 190 bp of nontranscribed sequence upstream of the acxA 
transcription start site that will be referred to as the acxA upstream regulatory region. The 
acxABC operon is under the control of a housekeeping a 80 promoter (41). The AT-rich region 
between the -35 and -10 sites of the acxA promoter along with the Pribnow box at the -10 site 
(TATACT) is typical o f H. pylori promoters (42). An inverted repeat (with one mismatch) 
directly upstream of the -35 site (TTATTaCAAA . . . TTTGaAATAA) is a potential binding 
site for transcription factors (Figure 2).
There is evidence that transcription of the acetone carboxylase operon, acxABC, is 
regulated directly or indirectly by all three TCST systems of H. pylori as well as the orphan 
response regulator HP 1021. HP 1021 has been shown to induce acxABC  transcription and to 
bind directly to the upstream regulatory region of acxA, but the mechanism of regulation has 
not been characterized in detail (35). Unpublished macroarray data obtained recently in our 
lab indicates that acxABC  is regulated by the CrdRS TCST system. Transcription of acxA is 
increased in H. pylori strains with null mutations in either crdR or crdS (43). It is interesting 
to note that another gene involved in acetone metabolism, fa d  A, exhibits similar de­
repression in the absence of a functional CrdRS TCST system (43). Direct interaction of 
CrdR and the acxA promoter has not yet been demonstrated, and a signal sensed by CrdS that 
affects acxABC transcription has not been identified. A CrdR-binding site containing a 
mirrored repeat (AACACC . . . CCACAA) has been identified directly upstream of the -35 
site of the crdA (a membrane-associated protein required for copper homeostasis) promoter, 
but the promoter region o f acxABC does not contain this sequence or any other mirrored 
repeats (27). As CrdR is an activator of crdA and a potential repressor of acxABC , it is 
possible that CrdR binds to a different DNA sequence when it acts as a repressor. Recent 
microarray data suggest that the genes of the acxABC operon are members of the pH-
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independent FlgRS regulon as well. Expression of all three genes in the acetone carboxylase 
operon was down-regulated in an flgS-H. pylori strain 26695 mutant in a manner irrespective 
of the pH of the growth media (31). The impact of deletion offlgR  on acxABC  transcription 
has not yet been studied. Because acxABC is not under the control of a a 54 promoter, the 
activation of acxABC  transcription in response to autophosphorylation of FlgS may occur by 
an alternate type of FlgR activity or may be mediated by another response regulator. Both 
full-length ArsR and the ArsR DNA-binding domain bind the upstream regulatory region of 
acxA in vitro, and acxABC  transcription is upregulated in an arsS- H.pylori strain J99 mutant 
(37). Transcription of acxABC  is also repressed at pH values <5.0 in H. pylori strains G27 
and 26695, but not in strain J99.
Constitutive expression of acxABC  would be inefficient for H. pylori, as acetone 
levels in human tissue are highly variable (40). Though no H. pylori protein that can sense 
and respond to changes in acetone concentration has been identified, acetone is a potential 
environmental signal that could lead to activation or derepression o f acxABC. H. pylori may 
also repress acxABC  transcription to respond to various types o f stress. Since acetone 
carboxylase is not necessary for survival, repression of acxABC  transcription by ArsRS at 
low pH and by CrdRS at increased levels of reactive oxygen species would allow more 
resources to be devoted to the acid acclimation or oxidative stress response.
Experimental Approach
The research described in this thesis represents a contribution to the comprehensive
characterization of transcriptional regulation of the acetone carboxylase operon via two-
component signal transduction in Helicobacter pylori. The overall aim of the experiments
described herein was to investigate whether the regulation of acxABC  expression by the H.
pylori transcription factors ArsR, CrdR, FlgR, and HP 1021 is direct or indirect, and to begin
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physical characterization o f the acxABC  regulation mechanism(s). Each o f these response 
regulators was cloned, overexpressed in E. coli, and purified. Electrophoretic mobility shift 
assays (EMSAs) were then employed to test for direct interaction o f each of the four H. 
pylori response regulators with DNA probes amplified from the upstream regulatory region 
of acxA.
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Methods
Cloning the Putative Upstream Regulatory Region of acxABC
A 756-bp product containing the putative upstream regulatory region of acxA was 
amplified from H. pylori J99 and 26695 genomic DNA using the Expand High Fidelity PCR 
kit, which includes a proofreading polymerase (Roche Diagnostics). PCR was performed in 
50 pF reactions with primers HP0694 FWD.2 and hyuA-R-2 (Table 1) according to the 
manufacturer’s instructions using a Gradient Multigene™ thermal cycler (Fabnet). Amplicon 
purification by agarose gel extraction was performed with the IBI Gel/PCR DNA Fragment 
Extraction Kit according to the manufacturer’s protocol (IBI). (This PCR protocol does not 
produce nonspecific amplification products, and gel purification may not be necessary in 
future work.) The purified PCR products were then ligated into the pCR2.1-TOPO® plasmid 
and transformed into OneShot® MAX Efficiency® D H 5a™ -TlR chemically competent E. 
coli (Invitrogen) (Table 2). After ampicillin selection and X-gal screening, three single 
colonies per transformation were inoculated in Furia-Bertani broth containing 100 pg/mF 
ampicillin (FB Amp) and incubated overnight at 37°C and 200rpm. Plasmid minipreps for 
pCR-J99-flcvX and pCR-26695-acxA were performed with the IBI High-Speed Plasmid Mini 
kit (Table 3). Sequencing reactions were performed using M l3 forward and reverse primers 
and Bigdye® Terminator v3.1 sequencing reagents (Applied Biosystems), and capillary 
sequencing was carried out on the Applied Biosystems 3130 Avant Genetic Analyzer. 
Samples of pCR-J99-acxA and pCR-26695-acxA showing 100% identity to the reference 
sequences in NCBI Genbank were kept to serve as templates for electrophoretic mobility 
shift assay (EMSA) probes. Freezer stocks of E. coli DH5a/pCR-J99-<2cvA and E. coli 
DH5a/pCR-26695-acxA were prepared with 15% glycerol and stored at -80°C.
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Table 1) Primers: Lower-case letters indicate added restriction sites.
Name 5’ to 3’ sequence
1 HP0694 FW D.l1 CAGGGTGGCTTTTACGATCACTG
2 hyuA-R-21 CGGTTCTTTCTGTAACGCCT
3 crdR Fwd.BamHI1 cccggatccATGCAAAAAAAGATTTTTTTACTAGAAGACG
4 crdR Rev.PstI1 cccctgcagTCATAGT GGGTT A A AGCG AT AGCC
5 HP 1021 Fwd.BamHI1 cccggatcc AT G A A A AT CTT A AT C ATT G AAG ACG
6 HP 1021 Rev.PstI1 cccctgcagTTATTTGCGCGGTAAGTTATATTTCCG
7 flgR Fwd.BamHI2 cccggatcc AT G AAAATCGCC ATT GT AG A AG AT G
8 flgR Rev.PstI2 cccctgcagCTACCTTTCCAAAAACAAATCTTTCT
9 pQE30 promoter3 CCCGAAAAGTGCCACCTG
10 pQE30 reverse sequencing3 GTT CT G AGGT CATT ACTGG
11 HP0694 FWD.l.btn2 Biotin-CAGGGTGGCTTTTACGATCACTG
12 acxA R ev l1 GGCATCAATACCCATCACC
13 HP0694 FWD.2.btn2 Biotin-TCCCAGCCTAAGCACCATC
14 acxARev2.btn Biotm-CTTTACCAACTACGAAACT
15 acxA-35Fwd2 AT G ATTTCC ATTT A A A A ATC
16 acxA-35Rev2 TT ATTT C A A AGTT GTTT GT
Cloning the Response Regulators
A freezer stock o f M l 5 E. coli known to express H. pylori 26695 ArsR was obtained
from Dan Hallinger (Table 2). Strains expressing FlgR, HP 1021, and CrdR were created for
this study by direct cloning or subcloning into the expression vector pQE30 (Qiagen) and
transformation into E. coli M l5. This vector confers ampicillin resistance, puts the inserted
gene under the control of the T5 promoter, and adds a 6xHis tag at the N-terminus. The entire
translated region of each of the H. pylori TCST response regulators was amplified from strain
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26695 genomic DNA using the Expand High-Fidelity PCR Kit. A BamHl restriction site was 
added to the 5’ end o f the forward primers and a PstI site added to the 5’ end of the reverse 
primers (primers 3-8 in Table 1) to facilitate ligation into the multiple cloning site of pQE30. 
PCR products were purified using an IBI PCR cleanup kit.
Table 2) Strains
Name Purpose Source
Helicobacter pylori 26695 Fully-sequenced cag PAI+ laboratory 
strain
Mark Forsyth, 
College of William 
and MaryH. pylori J99
OneShot® MAX Efficiency® 
DH5a™ -TlR chemically competent 
E. coli
Chemically competent E. coli for 
transformations
Invitrogen
JM 109 chemically competent E. coli Promega
M l5 chemically competent E. 
co/z/pREP4(kanR)
Dan Hallinger, 
Forsyth Lab, College 
of William and Mary
DH5a1M E. coli! pCR-26695- 
acxA(ampRkanR)
Template for production of EMSA 
probe for acxA upstream regulatory 
region
This study
DH5a1M E. co li/p C R -m -  
acxA(ampRkanR)
DH5cciM E. coli! pCR- 
26695 crdR( amp RkanR)
Stabilization and amplification of H. 
pylori response regulator genes prior to 
subcloning into expression vectorsDH5aIM E. coli! pCR- 
26695HP1021 (ampRkanR)
JM109 E. coli! pQE30-26695crdR 
(ampR)
Stabilization and amplification of H. 
pylori response regulator expression 
vectorsJM109 E. coli! pQE30-26695flgR 
(ampR)
JM109 E. colil pQE30-26695HP 1021 
(ampR)
M l5 E. colil pQE30-26695HP1021 + 
pREP4 (ampRkanR)
Expression of putative direct 
regulators of acxA in E. coli for use in 
EMSAsM15 E. colil pQE30-26695crdR + 
pREP4 (ampRkanR)
M l5 E. colil pQE30-26695flgR + 
pREP4 (ampRkanR)
M15 E. coli/ pQE30-26695arsR + 
pREP4 (ampRkanR)
D. Hallinger
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TOPO Cloning and Subcloning
Direct cloning into pQE30 can be problematic because it is not possible to determine 
prior to attempting ligation whether or not the restriction digest o f the intended insert has 
gone to completion. Therefore, TOPO cloning was performed when possible to ensure that 
any insert purified from a restriction digest o f the TOPO plasmid would be cut at both ends. 
TOPO cloning of the purified crdR and hpl021  PCR products was performed in the same 
manner as it was for acxA. Minipreps of the resulting transformants (DH5a E. co/z/pCR- 
26695crdR and DH5a E. ce>/z/pCR-26695hpl021, Table 2) were performed with the IBI 
High-Speed Mini Kit according to the manufacturer’s instructions. A 20% glycerol freezer 
stock was also prepared from each transformant and stored at -80°C. Three double digests 
each of pCR-26695crdR and pCR-26695HP1021 were prepared with BamYLl and Pstl 
according to the manufacturer’s protocol (Promega) and incubated 12-48h at 37°C. The 
products were run 1 h at 100 V on a 1.2% agarose gel and the crdR (641 bp) and hpl021 (836 
bp) insert bands were excised for purification. The three crdR insert bands were combined on 
one column and purified with the IBI Gel/PCR DNA Fragment Extraction Kit (Midsci) 
according to the manufacturer’s protocol, and the same was done for hpl021. This process 
was repeated and the products were concentrated together via ethanol precipitation until an 
adequate DNA concentration for ligation was reached (>5 ng/pL).
To prepare pQE30 for subcloning, a 15 mL JM109 E. co/z/pQE30 culture was grown 
overnight at 37°C in LB Amp with shaking. Four minipreps were performed with 3 mL 
culture each and the products were combined. Double digests of 1 pg total pQE30 were 
performed with Pstl and BamHI, with the DNA divided among as many replicate 20 pL 
reactions as necessary. A 2 pL aliquot of each product was run on a 1% agarose gel with 
ethidium bromide to check for uncut or nicked vector. Though uncut and cut pQE30 are
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Table 3) Plasmids
Name Description Purpose
pCR-26695-acxA acxA regulatory region from H. pylori 
strain 26695 cloned into pCR2.1- 
TOPO® (Invitrogen)
Template for PCR amplification 
of an EMSA probe from the 
acxA promoter and putative 
upstream regulatory region; 
confers kanamycin and 
ampicillin resistance
pCR-J99-acxA acxA regulatory region from H. pylori 
strain J99 cloned into pCR2.1- 
TOPO®
pQE30-26695arsR Entire arsR translated region cloned 
into expression vector pQE30 
(Qiagen)
Production of putative direct 
regulators of acxA in E. coli for 
use in EMSAs and in vivo 
experimentation; confers 
ampicillin resistancepQE30-26695crdR Entire crdR translated region cloned 
into expression vector pQE30
pQE30-26695flgR Entire flgR  translated region cloned 
into expression vector pQE30
pQE30-26695HP 1021 Entire HP 1021 translated region 
cloned into expression vector pQE30
distinguishable on the gel, the bands run too close to each other to separate by gel 
purification, so digests that did not go to completion were discarded. Liquid purifications of 
successful digests were combined on one spin column and purified with the IBI Gel/PCR 
DNA Fragment Extraction Kit. The product was then treated with shrimp alkaline 
phosphatase (Promega) according to the manufacturer’s protocol to prevent re-ligation of 
single-cut pQE30. (Single-cut pQE30 could not be distinguished from double-cut pQE30 on 
a test gel, and early trials without SAP treatment yielded mostly transformants carrying self­
ligated pQE30.) SAP-treated pQE30 was purified and concentrated via ethanol precipitation 
until a DNA concentration o f at least 10 ng/pL was obtained. The cut crdR and hpl021 
inserts were ligated into pQE30 with T4 DNA ligase (Promega) to create pQE30-26695crdR 
and pQE30-26695hpl021 (Table 2). Reactions were performed with an approximate 6:1 
vector to insert ratio by mass and were incubated overnight at 14°C.
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Although M l 5 E. co/z/pREP4 was used as the host strain for expression of the cloned 
response regulators, the newly ligated plasmids were first transformed into JM109 E. coli as 
this strain is better for storage and propagation of plasmids. Strains JM109 E. coli!pQE30- 
26695crdR and JM109 E. coli/pQE30-26695hpl021 (Table 3) were created according to a 
protocol adapted from the Promega GeneEditor™ handbook: Two LB Amp agar plates per 
transformation were pre-warmed at 37°C. One 100 pL glycerol stock o f chemically 
competent JM109 E. coli per transformation was thawed on ice and transferred to a pre­
chilled 2 mL sterile tube. A 2-10 pL portion o f the ligation reaction product was added to the 
cells and the mixture was incubated 30 minutes on ice. The cells were heat-shocked 45-50 s 
at 42°C, then incubated 2 min on ice. For recovery, 900 pL room temperature SOC broth was 
added to each vial and the cells were incubated 90 min at 37°C and shaking horizontally at 
225 rpm. Two LB Amp plates, one with 100 pL transformed cells and one with 10 pL, were 
spread per transformation. After an overnight incubation at 37°C, 5 colonies per 
transformation were inoculated into 5 mL LB Amp broth each and grown overnight at 37°C 
with shaking. Freezer stocks with 20% glycerol were prepared from each 5 mL culture and 
stored at -80°C. Minipreps, restriction digests, and agarose gel electrophoresis were 
performed as described above to confirm successful transformation and presence of the 
correct size insert in pQE30. Sequencing of successfully transformed plasmids was 
performed as described above for acxA to confirm that crdR and hpl021  had been inserted in 
frame with the lac promoter and 6xHis tag and were identical to the reference sequence in 
Genbank. Minipreps of pQE30-26695crdR and pQE30-26695hpl021 were stored at -20°C. 
Once the correct sequence was confirmed, pQE30-26695crdR and pQE30-26695hpl021 
were transformed into M15 E. coli as specified in the QIAexpressionist™ manual (Qiagen) to
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create M15 E. co/*/pQE30-26695crdR + pREP4 and M15 E. colilpQE30-26695hpl021 + 
pREP4 (Table 3).
Direct Cloning
Because the digestion of pCR®-2.1-TOPO® with Pstl and BamHI produces a 1210 
bp fragment that cannot be gel-purified separately from flgR  (1145 bp), this gene was not 
subcloned. Double digests of the flgR  PCR products were prepared with BamHI and Pstl as 
described above. The products of multiple restriction digests were purified and concentrated 
together via ethanol precipitation until an adequate concentration for the ligation reaction was 
reached. Ligation into pQE30 and transformation into the host strains was performed as 
described above to create JM109 E. coli/pQE30-26695flgR, and then M l5 E. coli/pQE30- 
26695flgR + pREP4 (Table 2).
Response Regulator Expression and Extraction
Soluble ArsR was expressed in and extracted from M l5 E. co/z/pQE30-26695arsR + 
pREP4 according to the native batch purification protocol in the QIAexpressionist manual. 
This protocol did not produce soluble products for the other three response regulators, and 
had to be optimized as follows: A freezer stock of M15 E. coli carrying pQE30 with the 
response regulator gene o f interest was used to inoculate an overnight culture in 10 mL LB 
Amp Kan (100 pg/mL ampicillin and 50 pg/mL kanamycin) broth. The next day, this entire 
culture was added to 250 mL prewarmed LB Amp Kan in a sterile baffled flask. This culture 
was grown at 37° with shaking to an OD6oo of 0.5-0.7. A 1 mL uninduced control sample was 
taken from the culture, pelleted in the microcentrifuge, and reuspended in 50 pL lx  SDS- 
PAGE sample buffer. Expression was induced by adding IPTG to a final concentration of 1 
mM, and the culture was returned to the incubator. Every hour or half hour, a 1 mL induced
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control sample and a 50 mL sample for protein extraction were taken from the culture. Both 
samples were pelleted immediately. The induced control pellet was resuspended in 100 pL lx 
SDS-PAGE sample buffer, and the 50 mL pellet was drained and frozen overnight at -20°C. 
The next day, a solubility test was performed on protein extracted from each 50 ml sample 
taken during the time-course according to a protocol adapted from the QIAexpressionist 
manual: Cell pellets were thawed on ice and resuspended in 2 mL NPI-10 lysis buffer (50mM 
NaH2P0 4 , 300mM NaCl, lOmM imidazole) per gram. Lysozyme was added to a final 
concentration of 1 mg/mL cell suspension and samples were incubated 30 minutes on ice.
The resuspended cells were then sonicated at maximum power on ice in six 10 second bursts 
with a 10 second cooling period between each burst. Twelve units Benzonase® nuclease 
(Novagen) per mL expression culture was added to each sonicated sample and the mixtures 
were incubated 15 min on ice. The lysates were then centrifuged for 30 min at 10,000 g and 
4°C to pellet the cell debris. The supernatant, which is the soluble fraction, was removed and 
stored at 4°C. The insoluble fraction (pellet) was resuspended in a volume of NPI-10 equal to 
the volume of the supernatant and stored at 4°C. A 20 pL aliquot o f each fraction was taken 
for SDS-PAGE. Equal volumes of the aliquots of the uninduced control, induced control, 
soluble fraction, and insoluble fraction from each time point were run on SDS-PAGE gels 
and stained with Coomassie Blue to evaluate expression levels and solubility. SDS-PAGE 
was performed using 12% acrylamide 0.75 mm thick gels on the BioRad Mini-PROTEAN® 
apparatus. The time point that produced the largest amount o f the desired protein in the 
soluble fraction was selected as the expression time for subsequent purifications. If the 
protein was largely insoluble at all time points, adjustments were made to slow expression in 
order to avoid inclusion body formation. These included using reduced IPTG concentrations, 
growth at a lower temperature, and the addition of 1% glycerol to the media. Through this
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optimization procedure, the following adjustments were made to the QIAexpressionist 
protocol for the three remaining response regulators: M l5 A. coli expressing HP 1021 were 
grown in 250 mL cultures and harvested 2 h post-induction. Expression cultures for FlgR 
were grown in a total volume of 1 L per purification and were harvested 1 h post-induction. 
The lysis buffer for FlgR cultures contained 0.1% Tween-20. M15 E. coli expressing CrdR 
were grown in LB Amp Kan with 1% glycerol at 18°C, were induced with 0.1 mM IPTG, and 
were harvested 4 h 35 min after induction.
Response Regulator Purification
ArsR, CrdR, and HP 1021 were purified on 5 mL bed volume drip columns containing 
3 mL 50% Ni-NTA agarose slurry according to the manufacturer’s protocol (Qiagen). Up to 
twelve milliliters of the soluble fraction of each protein extract could be processed in one 
purification. For FlgR, which required more stringent conditions than the other response 
regulators, Tween-20 was added to all lysis, wash, and elution buffers to 0.1%, and six 
elutions were performed instead of four. During purification, a 20 pL aliquot of each fraction 
was taken for SDS-PAGE, which was performed to check the quality o f the purification and 
to determine which elution fractions to save for use in EMSAs. These fractions were chosen 
on the basis of total protein concentration as measured on the Nanodrop spectrometer 
(Thermo), and purity as observed on the gel. If the fractions to be reserved contained less 
than 2 mg/mL total protein, they were concentrated using a 10K Microsep™ column 
according to the manufacturer’s instructions (Pall Life Sciences). The reserved fractions were 
pooled and glycerol was added to 10%. Aliquots containing 60 pg protein were prepared and 
stored at -20°C. Each aliquot was discarded after a maximum of three freeze-thaw cycles. A
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colorimetric Western blot was performed with an a-His antibody according to the Qiagen 
Detection and Assay handbook to confirm the identity of the purified proteins.
Electrophoretic Mobility Shift Assays 
Response Regulator Phosphorylation
ArsR, CrdR, and FlgR were phosphorylated for use in EMSAs according to the 
protocol employed by Loh for ArsR (37). Though there is no evidence that HP 1021 can be 
phosphorylated, this response regulator was put through the same phosphorylation reaction 
for control purposes. No phosphorylation protocol existed for FlgR, so the ArsR protocol was 
used. Further optimization may improve EMSA results with FlgR. Though a combined 
phosphorylation and binding protocol exists for CrdR (27), no results were obtained when it 
was attempted in this study. (That is, this protocol produced a completely blank EMSA blot.)
Because the proteins are diluted in the phosphorylation reaction and because the 
phosphorylation buffer is different from the EMSA binding buffer, it was necessary to use 
10K Microsep™ columns to re-concentrate the phosphorylated response regulators. The 
proteins were concentrated to at least 1 mg/mL (1.5 mg/mL for FlgR) and glycerol was added 
to 10% by volume. The response regulators were split into 60 pg aliquots as before and 
stored at -20°C. They were discarded after a maximum of three ffeeze-thaw cycles, including 
any that took place before phosphorylation.
Probes
EMSAs were performed with biotin-labeled DNA probes that could be visualized
using the LightShift® Chemiluminescent EMSA Kit (Thermo Scientific). These probes
(Table 4, Figure 2) were amplified by PCR from the templates pCR-26695«cvHRC and pCR-
J99acxABC (or later, from existing probe stocks) using the Expand High Fidelity PCR kit and
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biotinylated primers (Table 1). Unlabeled probes for competition assays were produced by 
the same method. Unlabeled probes were purified with an IBI PCR cleanup kit.
Because the acxA-All* probes produced a large smear when visualized on a 
chemiluminescent blot, they were initially purified with an IBI gel extraction kit. The acxA- 
Up* probes were co-amplified with a -250 bp contaminant and the acxA-Down* probes were 
co-amplifled with a -200  bp contaminant. These contaminants were difficult to remove by 
agarose gel extraction and are visible in some of the EMSA results, but acrylamide gel 
purification eventually yielded pure samples of all three types of probe. For purification, 
fresh PCR products were run on 6% acrylamide native gels containing 4 pg/mL ethidium 
bromide. The probe bands were then excised and purified according to the crush and soak 
method (44): Gel slices containing the DNA to be purified were pulverized in a
Table 4) Probes for acxABC  EMSAs
Probe
Name
Description Size
acxA-All Spans entire putative upstream regulatory region of H. pylori acxABC 370 bp
acxA-All* Biotinylated acxA-All
acxA-Up Spans end of HP0694 translation through -35 site of H. pylori acxABC 209 bp
acxA-Up* Biotinylated acxA-Up
acxA-Down Starts at -35 site of H. pylori acxABC and ends downstream of the start of 
translation
175 bp
acxA-Down* Biotinylated acxA-Down
Glc.kin Unlabeled non-regulatory sequence from the translated region of the E.coli 
glucokinase gene.
151 bp
EBNA Unlabeled Epstein-Barr nuclear antigen DNA from the LightShift® EMSA 
Optimization kit (Thermo); includes some viral regulatory sequence.
60 bp
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5'-TTATTACAAACAACTTTGAAATAAATGATTTCCATTTAAAAATCAGCCTTATACTTCTAATA-3'
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Figure 2. Sizes and locations of acxA EMSA probes used in this study and others. This schematic 
shows base pairs 745441-745920 of the H. pylori strain 26695 genome. My acxA-All probe, Pflock’s 
acxA probe, and Loh’s acxA probe all contain the promoter region of acxA and extend past the start of 
acxA translation, so they are considered functionally equivalent for the purposes of this thesis (35, 37). 
The acxA-Up probe was designed to include potential proximal binding sites for transcriptional 
activators of acxA, and acxA-Down was expected to include binding sites for acxA repressors. The
magnified region shows the promoter sequence, which resembles the typical H. pylori housekeeping
80a  promoter including the extended Pribnow box (tgnTAtaAT) at -10 bp (underlined) and AT-rich 
region between the -10 and -35 sites (41, 42). Dashed underlines indicate inverted repeats, a potential 
binding site for response regulators.
microcentrifuge tube, mixed with three volumes elution buffer (300 mM sodium acetate, 
ImM EDTA pH 8.0), and shaken 24-72 hours at room temperature and 200 rpm. The 
samples were centrifuged 10 minutes at 10,000 g to pellet the gel fragments, and the probe 
was purified from the supernatant by ethanol precipitation.
Electrophoretic Mobility Shift Assays 
Binding Reactions
EMSAs were carried out according to a procedure adapted from the LightShifit® 
EMSA Optimization kit protocol, the Sigma EMSA Optimization kit protocol, and the ArsR 
EMSAs performed by Loh et al (37). Each experiment comprised 5-7 binding reactions 
which were run on native PAGE gels and blotted. The following is a typical set of reactions:
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1) Labeled probe
2) Labeled probe + Unphosphorylated protein
3) Labeled probe + Unphosphorylated protein + 500x Unlabeled probe
4) Labeled probe + Unphosphorylated protein + 500x Unlabeled nonspecific DNA
5) Labeled probe + Phosphorylated protein
6) Labeled probe + Phosphorylated protein + 500x Unlabeled probe
7) Labeled probe + Phosphorylated protein + 500x Unlabeled nonspecific DNA
In early experiments, unphosphorylated response regulators were not expected to 
produce a shift, so reactions 3 and 4 were not included. These reactions were added to each 
EMSA after ArsR was observed to produce a shift without phosphorylation. The amount of 
unlabeled probe in reactions 3, 4, 6, and 7 was the same for all samples in one EMSA, but 
was varied between experiments in an effort to obtain more information about binding 
specificity. In each EMSA, the amount of protein in reactions 2-4 was the same, as was the 
amount in reactions 5-7.
Each binding reaction in an EMSA had a total volume o f 30 pL. Reagents were 
combined in this order: 6 pL 5x binding buffer, 2 pL poly dl-dC (1 mg/mL), unlabeled probe 
(if applicable), 0.2-0.4 nmol protein (if applicable), and dl H20  to 29 pL. This mixture was 
incubated 10 minutes at room temperature. Next, 1 pL (1-2 ng) labeled probe was added to 
each binding reaction and incubated 20 minutes at room temperature. Reactions were 
electrophoresed immediately after this incubation was complete.
The binding buffers for ArsR and HP 1021 were based on previous studies. For ArsR, 
the 5x binding buffer contained 50 mM Tris-HCl, 250 mM KC1, 5 mM DTT, 12.5% glycerol, 
25 mM MgCl2, and 0.25% NP-40 (37). The 5x HP 1021 binding buffer contained 50 mM 
Tris-HCl, 50 mM KC1, 5 mM DTT, 5% glycerol, and 25 mM EDTA (35).
There was no existing EMSA protocol for FlgR when this study began, so two
binding buffers were tested and the ArsR binding buffer was found to be superior to the
buffer specified by the LightShift® base protocol. Because the combined phosphorylation
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and binding protocol for CrdR described above yielded no results, the 5x ArsR binding buffer 
was used for CrdR as well. Further optimization may improve EMSA results for FlgR and 
CrdR.
Electrophoresis
7.5 pL loading buffer (Thermo) was added to each binding reaction in preparation for 
gel electrophoresis, and 18 pL of each binding reaction was loaded onto a 6% acrylamide 
native PAGE gel. (Though 4% acrylamide gels are traditionally used for EMSAs, 6% 
acrylamide was the minimum concentration at which the especially thin gels required by our 
electrophoresis cell could be transferred to the blotting apparatus intact.) Gels were pre- 
electrophoresed at least 30 minutes at 100 V before loading. The binding reactions, along 
with 0.5 pg 2-log biotinylated DNA ladder (New England Biolabs) in the first and last lanes, 
were electrophoresed in 0.5x TBE at 100 V until the unbound biotinylated probe was ~5 mm 
from the bottom edge o f the gel. Gels containing EMSAs performed with the larger “All” 
probes were run 2 h 40 min, and those performed with the “Up” or “Down” probes were run 
until the light blue xylene cyanol loading dye band reached the bottom of the gel.
Blotting and Detection
Tank blotting onto Zeta-Probe GT® nylon membranes was performed immediately 
after electrophoresis according to the manufacturer’s protocol for the BioRad Mini Trans- 
Blot® cell. The fiber pads, filter paper, and membranes were soaked in 0.5x TBE at least 10 
minutes before the blotting cartridges were assembled. Transfers were performed in chilled 
0.5x TBE for 30 minutes at 380 mA. Blots were crosslinked while still damp in a 
Stratalinker® UV crosslinker and were stored dry at room temperature until the detection 
procedure could be performed (Stratagene).
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Detection was carried out according to the LightShift® EMSA kit protocol. The 
finished blots were exposed immediately to Thermo Scientific CL-XPosure® X-ray film for 
10 s. The film was developed in a Konica automated film processor. If  the blot was too 
bright, shorter exposures were performed. If no band appeared where one was expected, 
longer exposures were performed up to and including a “burnout” exposure in which the blot 
and film were left in the exposure cassette much longer than the 30 minutes for which the 
luminescence o f the blot was expected to persist.
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Results and Discussion
ArsR Mobility Shift Assay
All ArsR electrophoretic mobility shift assays (EMSAs) were performed using DNA 
probes amplified from the cloned upstream regulatory region o f Helicobacter pylori strain 
26695 acxA unless stated otherwise (Table 4, Figure 2). The results in Figures 3-5 show that 
response regulator ArsR from H. pylori strain 26695 binds the acxA upstream regulatory 
region both upstream and downstream of the -35 site of the promoter, whether or not the 
protein has been phosphorylated in vitro. (Phosphorylated ArsR is abbreviated as ArsR-P.) 
This is in agreement with previous EMSA results obtained using both the DNA-binding 
domain (DBD) of ArsR and the full-length protein from Helicobacter pylori strain J99 using 
a probe that included the entire acxA promoter region (Figure 2) (37). In Foh’s study, a shift 
occurred in a binding reaction with full-length ArsR~P (3 pM) and labeled acxA probe (100 
pM), and specific competition was observed in a reaction that contained ArsR-DBD (2 pM), 
labeled probe (100 pM), and a 20-fold excess of unlabeled probe. No competition reactions 
were performed in this study with full-length ArsR. A recent review contends that the DNA- 
binding domains of response regulators tend to have greater affinity for their target DNA than 
their full-length counterparts, but my results combined with Foh’s suggest that this may not 
be true for ArsR, as specific competition appears to occur more readily in EMSA reactions 
with the ArsR DBD than with full length ArsR (8).
Binding Specificity of ArsR to acxA Probes
In each EMSA, competition reactions are performed to examine binding specificity 
between the response regulator and its target sequence. Unlabeled probe identical to the 
labeled probe is added to one binding reaction to test for specific competition, and the same
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amount of an unlabeled probe amplified from an unrelated gene (containing either no 
regulatory sites or regulatory sequence from a different species) is added to another binding 
reaction to test for nonspecific competition. In order for this assay to produce the most 
meaningful data regarding binding specificity, at least some specific competition must be 
observed. In the ArsR EMSAs exemplified by Figure 3, specific competition was only 
demonstrated once in a binding reaction with the acxA-All probe despite the competition 
reaction being performed seven times with up to 1200x unlabeled probe. It is not certain why 
specific competition was so difficult to demonstrate in this binding reaction, especially when 
competition occurred in Loh’s competition reactions performed with ArsR-DBD at a 20-fold
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Figure 3. ArsR EMSA with acxA-All probe. An asterisk indicates biotinylated probe, and “~P” 
following the name of a protein indicates that it has been phosphorylated. See Table 4 for probe 
descriptions. First and last lanes: 2-log biotinylated DNA ladder (New England Biolabs). All reactions 
contain 2 ng acxA-All* amplified from Helicobacter pylori strain 26695, and reactions 2-5 contain 10 pg 
protein. Reactions 2 and 3 were performed to test for the formation of probe/protein complexes, and 
reactions 4 and 5 were performed to assess binding specificity. The gel was accidentally stretched 
upwards at lanes 1-3 while being transferred to the blot apparatus. In six similar (with the exception of 
the amount of acxA-All*; 1 ng) assays with up to 1200x specific competitor, the same acxA-All*lpxoitm 
complexes were observed but the results for specific competition were negative (data not shown).
Similar results (not including specific competition) were obtained when the same EMSA was performed 
three times using acxA-All probe amplified from pCR.A99-acxA (Table 2).
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excess of unlabeled probe (37). Attempts to replicate specific competition results in this study 
by decreasing the amount of protein in the reaction and increasing the amount of unlabeled 
probe were unsuccessful (data not shown). Upon review of experimental records, it was 
discovered that 2 ng o f labeled acxA-All was added to the binding reactions in Figure 3 
instead of 1 ng as for all other EMSAs with this probe. It is possible that the amount of 
competition that occurred in the ArsR and acxA-All EMSAs was so small that it could only 
be visualized when the amount of labeled probe in the reaction was accidentally doubled. The 
reaction conditions necessary to demonstrate specific competition, and therefore binding 
specificity, with full-length ArsR and probes containing the whole upstream regulatory 
region of acxA will require optimization.
However, considering the molar ratios of the binding reaction components, it is 
surprising that competition occurred in the EMSA in Figure 3 or in Loh’s EMSA at all. When 
the binding reactions are assembled, the protein and unlabeled probe are co-incubated, and 
then the labeled probe is added. If there is enough free protein still available after the first 
incubation for the labeled probe to bind, then all of the labeled probe will be shifted and no 
evidence of competition will appear on the blot. Because the affinity o f the protein for the 
labeled and unlabeled probe should be equal, competition should occur only if  there is a 
shortage of protein available for binding. Loh’s binding reactions that produced competition 
contained as much as 1000 times more ArsR protein than total probe. Given this ratio one 
might expect that all o f the acxA probe, labeled and unlabeled, would have been shifted and 
no visible competition for ArsR-DBD would have occurred. A possible explanation is that 
although there was a 1000-fold excess of total protein in the binding reactions, only a small 
percentage of this protein was ArsR-DBD in a state that was capable of binding its acxA 
target sequence. Purity o f the ArsR solutions used in EMSAs is not discussed in Loh’s study,
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but the ArsR content o f the protein extracts produced for this thesis work using a similar 
protocol was visually estimated to be >75% based on SDS-PAGE results. Even then, Loh’s 
binding reactions would still have contained at least a 750-fold excess o f ArsR. In this case, 
competition only could have occurred if  the majority of this ArsR was in a state or 
conformation that was unable to bind to the probe.
The Effect of Potential Active and Inactive States of Response 
Regulators on Competition Assays in EMSAs
The hypothesis that TCST response regulators, whether phosphorylated or 
unphosphorylated, exist in an equilibrium between active and inactive states is discussed in 
Bourret’s review of two component signal transduction (Figure 4) (8). According to this 
theory, the active state o f a response regulator is able to bind DNA and regulate gene 
expression and the inactive state binds its target sequence with very low affinity if  at all. 
Bourret contends that phosphorylation shifts the equilibrium toward activation, but it is 
possible that only a very small fraction o f the response regulator is active at a time whether it 
is phosphorylated or not. Assuming this is true of ArsR, it could be that competition occurred 
in Figure 3 and in Loh’s ArsR-DBD EMSAs because despite the large excess of total protein 
over total probe, there was actually an excess of total probe over active ArsR. (This is not 
necessarily representative o f the activity o f ArsR in vivo; it could be an artificial effect of the 
experimental phosphorylation or binding conditions.)
Potential Multiple Binding Sites for ArsR in the acxA Upstream 
Regulatory Region
Reactions 2-5 of the EMSA in Figure 3 also produced a minor band that was less
mobile than the major ArsRlacxA-All complex. This may represent a supershift that occurs
when ArsR bridges two probe molecules by binding them simultaneously, and if so would be
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Figure 4. Proposed model for activity of ArsR with respect to acxA regulation. ArsR may exist in 
an equilibrium between inactive and active states. The active state is able to bind DNA, and the inactive 
state cannot. Phosphorylation of ArsR increases its ability to repress acxA transcription by shifting the 
equilibrium toward the active state.
an artifact of the EMSA. (The term “supershift” refers to a larger than normal shift observed
in an EMSA, and its specific definition varies with the parameters of the assay. For example,
one recombinant protein tagged with a 6xHis epitope binds to one DNA probe and generates
a shift in a hypothetical EMSA. A supershift could be obtained by adding an a-His antibody
to the binding reaction, which would increase the molecular weight and size of the
DNA/protein complex.) It is also possible that there are multiple binding sites for ArsR in the
acxA upstream regulatory region, and that this less-mobile band represents an ArsR/acxA-All
complex with a higher molecular weight due to the involvement of additional ArsR
molecules bound to distinct sites on the DNA probe. The results in Figure 3 do not indicate
how many ArsR molecules are involved in each o f the two potential complexes. Repetition of
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this assay using a gel with longer lanes may allow detection o f additional ArsRJacxA-All 
complexes, which could aid in determining the number o f ArsR binding sites in the acxA 
upstream regulatory region.
ArsR EMSAs performed with shorter acxA regulatory region probes, acxA-Up and 
acxA-Down (Table 4), provide more direct evidence of multiple binding sites for ArsR. ArsR 
and ArsR~P EMSAs performed with probes containing only the portion of the putative acxA 
regulatory sequence upstream of the -35 site (acxA-Up) were positive for specific binding 
(Figure 5). No full competition was observed in reactions with 5 pg protein and up to a 290- 
fold excess of specific competitor, but an intermediate band that migrated between the free 
probe and the fully-shifted probe/protein complex was observed in specific competition
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Figure 5. ArsR EMSAs with acxA-Up probes, (a) ArsR and acxA-Up EMSA/ArsR~P and acxA-Up 
EMSA with competition test. Leftmost lane: 2-log biotinylated DNA ladder (New England Biolabs). 
Reactions 1-5 contain 1 ng acxA-Up* and reactions 2-5 contain 5 pg protein. The acxA-Up* probe 
stock used in this EMSA contained a larger contaminant, a biotinylated nonspecific PCR product that 
was not resolved separately from the probe in agarose gel purification and which may have interfered 
with the competition assay. Acrylamide gel purification eliminated this contaminant from future 
EMSAs, including Figure 3b. This image represents results obtained in two replicate assays. Similar 
results were obtained when the same EMSA was performed using acxA-Up probe amplified from pCR- 
J99-acxA (Table 2). (b) ArsR and acxA-Up EMSA with competition test. Leftmost lane: 2-log 
biotinylated DNA ladder (New England Biolabs). Reactions 1-4 contain 0.7 ng acxA-Up* and reactions 
2-4 contain 5 pg ArsR. The band labeled “intermediate shift” is the result of competition, not the 
contaminant.
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reactions. These results point to two ArsR binding sites on the acxA-Up probe, one with 
higher affinity and one with lower affinity for ArsR and ArsR~P. I hypothesize that in 
reactions without the specific competitor, there is enough ArsR to bind both sites on all of the 
acxA-Up probes, producing only the full shift. In the specific competition reactions (Figure 
5b, lane 3), there is a limited amount of unbound ArsR available when the labeled probe is 
added. ArsR binds the higher-affmity site on every acxA-Up probe first, then begins to bind 
the low-affmity sites. The acxA-Up probes with ArsR only bound to the higher-affmity site 
account for the intermediate shift.
ArsR and ArsR~P EMSAs performed with probes containing the acxA regulatory 
sequence downstream of the -35 site (acxA-Down) were also positive for specific binding 
(Figure 6). In competition reactions performed with 10 pg ArsR~P and 50x unlabeled acxA- 
Down, both full and intermediate shifts were observed. In competition reactions performed 
with 5 pg ArsR, a 30-fold excess of specific competitor eliminated the full shift and produced
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Figure 6. ArsR EMSAs with acxA-Down probes, (a) ArsR and acxA-Down EMSA/ArsR~P and 
acxA-Down EMSA with competition test. Reactions 1-5 contain 1 ng acxA-Down* and reactions 2-5 
contain 10 pg protein. Leftmost lane: 2-log biotinylated DNA ladder (New England Biolabs), (b) ArsR 
and acxA-Down EMSA with increasing amounts of specific competitor. Reactions 1-4 contain 1 ng 
acxA-Down* and reactions 2-4 contain 5 pg ArsR. Leftmost lane: 2-log biotinylated DNA ladder.
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an intermediate shift and free probe. In conclusion, ArsR~P appears to bind acxA-Down with 
slightly greater affinity than ArsR, and the DNA sequence within the probe acxA-Up may 
contain higher-affmity binding site(s) for ArsR and ArsR~P than acxA-Down. I hypothesize 
that the intermediate shift seen in the ArsR EMSAs indicates that acxA-Down also contains at 
least two ArsR binding sites, one with greater affinity for ArsR than the other. Thus the 
combined results of the EMSAs shown in Figures 3 and 4 support a model of regulation of 
acxA expression involving four binding sites for ArsR in the acxA upstream regulatory 
region. In Loh and Cover’s study, intermediate shifts were observed in ArsR EMSAs 
performed with probes amplified from the promoter regions of the target genes rocF and 
arsR, suggesting that multiple ArsR binding sites may be part of a consistent mechanism for 
this response regulator (37).
A Model for Repression of acxA Transcription by ArsR
Figure 7 is a model of ArsR activity based on the results o f this study and other
currently available data. I hypothesize that ArsR, a repressor of acxA transcription according
to qRT-PCR and microarray data from two independent studies (37, 6), binds to the acxA
promoter at two sites upstream and two sites downstream of the -35 position. ArsR binds to
the upstream sites with higher affinity than the downstream sites. In this model, transcription
of acxA is repressed when ArsR binds to all four sites, but otherwise acxA transcription may
proceed. (Depending on the positions of the two binding sites downstream of the -35 site, it is
also possible that acxA transcription may also be repressed when only three ArsR molecules
are bound.) As unphosphorylated ArsR is mostly inactive, it would be unlikely to form a
stable acxA repression complex but may bind transiently to any site. This could lead to
“leaky” repression o f acxA transcription by unphosphorylated ArsR, which may have an
advantage over no repression at all in terms o f resource conservation. When ArsR is
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Figure 7. Proposed model for the function of multiple binding sites in transcriptional regulation
of acxA by ArsR. ArsR binding sites are labeled 1-4, from highest to lowest affinity. Sites 1 and 2 are 
both upstream of the -35 site, and sites 3 and 4 are both downstream of the -35 site. The locations of 
these sites are otherwise unknown, and the positions of sites 3 and 4 may be reversed. In this model, 
due to existing primarily in the inactive state (see Figure 4), unphosphorylated ArsR is most likely to be 
unbound or bound only to the high-affinity upstream acxA regulatory sites, which allows for acxA 
transcription. Phosphorylation of ArsR causes the majority of this response regulator to be in the active 
state, which is more likely to bind all four sites simultaneously and repress acxA. Protein-protein 
interactions between the bound ArsR molecules could stabilize the acxA repression complex.
41
phosphorylated in response to a signal from ArsS, the equilibrium would shift so that ArsR~P 
was mostly in the active state, and would therefore be more likely to bind at all four of its 
sites in the acxA regulatory region. If the ArsR~P molecule bound to the lowest-affinity site 
interacts with another one of the ArsR~P molecules in the complex while they are both bound 
to the DNA, this could serve to stabilize the repression of acxA. The possibility of protein- 
protein interaction between the bound ArsR~P molecules was included in this model due to 
the structural similarity of ArsR to OmpR (20).
The placement of the binding sites in Figure 7 is partially informed by the DNA 
sequence and EMSA results, and partially arbitrarily determined: The highest-affmity site 
(#1) is placed directly upstream of the -35 site because this is the location of a set of inverted 
repeats. Though a consensus binding site for ArsR has not been identified, the helix-tum- 
helix m otif in the ArsR DBD indicates that ArsR binding sites are likely to 
contain repeats. Site #2 is therefore placed further upstream, though its position could be 
anywhere between 59 bp and 244 bp before the start of acxA transcription. Though two ArsR 
binding sites are likely to exist between the -35 site of the acxA promoter and the end of the 
acxA-Down probe (140 bp downstream of the transcription start site), the position of these 
sites relative to each other and the promoter is unknown.
The requirement for four ArsR molecules to bind the acxA regulatory region 
simultaneously to repress transcription would dampen the signal transduced by ArsRS. This 
could keep acxA repression by ArsR-P from occurring in response to transient acid exposure, 
which combined with leaky repression by ArsR would allow acxABC  to respond to low pH in 
a less sensitive manner than other members of the ArsRS regulon. This could represent two 
slightly different regulatory mechanisms carried out by the same TCST system, which if
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correct could lead to greater understanding of how H. pylori compensates for its relatively 
small number o f transcriptional regulatory systems.
CrdR Mobility Shift Assay
While the results o f the EMSA shown in Figure 8 are somewhat less than clear and 
the current CrdR EMSA protocol developed in this study requires further optimization, some 
information may be gleaned from this experiment. First, while excess glycerol in the binding 
reactions may have resulted in smearing, it is not known to retard the motion of DNA 
through the gel (45). Therefore, the position of the labeled probe in lanes 2-5 is almost 
certainly due to interaction with purified H. pylori recombinant CrdR. It also appears that 
unphosphorylated CrdR produces a larger shift than phosphorylated CrdR. This could 
indicate that unphosphorylated CrdR has a greater affinity for the probe, or that the probe 
contains multiple CrdR binding sites. If there are multiple binding sites for CrdR in the acxA 
regulatory region, it is possible that CrdR can bind to more of these sites than CrdR~P, and 
that the CrdR/probe complexes therefore have a higher molecular weight than the 
CrdR~P/probe complexes. It is also possible that CrdR and CrdR~P each bind the probe at 
the same number o f sites, but form protein/DNA complexes with different shapes resulting in 
different mobilities.
Previous results have indicated that expression o f acxA increases in crdR- and crdS-
strains of H. pylori, suggesting that CrdR~P is a repressor of acxA transcription (43). Because
CrdS responds to environmental stress (either by sensing excess Cu2+ or reactive oxygen
species), the repression of acetone carboxylase expression by CrdR may follow a pattern
similar to the acid stress response carried out by ArsR. Expression of acxABC  may be
repressed when CrdS senses oxidative stress so that more resources can be devoted to the
oxidative stress response, and multiple CrdR binding sites in the acxA upstream regulatory
43
region could dampen the sensitivity o f this response as proposed above for ArsR. It is also 
possible that CrdR represses acxA expression in response to another unidentified 
environmental signal. Additional EMSAs with an optimized binding protocol and probes 
designed to elucidate the CrdR binding site(s), at least one of which is expected to be on or 
downstream of the promoter due to CrdR being a putative repressor o f acxA, will be 
necessary to provide meaningful insight into this function of CrdR.
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Figure 8. CrdR and acxA-All EMSA optimization. This assay was performed to compare several 
EMSA binding protocols following an unsuccessful EMSA that was performed with 2 pg CrdR/CrdR-P 
per reaction and the ArsR protocol. Leftmost lane: 2-log biotinylated DNA ladder (New England 
Biolabs). Reactions 1-5 contain 1 ng acxA-All*, and reactions 2-5 contain 6 pg protein. The CrdR-P 
used in this assay was phosphorylated according to the ArsR protocol. Two reactions performed 
concurrently using a published CrdR phosphorylation and EMSA protocol produced no results (data not 
shown) (27). Smearing is likely due to excess glycerol in the binding reactions.
FlgR Mobility Shift Assay
In an EMSA with acxA-All probe, results for both FlgR and FlgR~P were positive for 
binding (Figure 9). However, binding appeared to be weaker than that o f ArsR and may be
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nonspecific. Complete competition occurred in FlgR~P EMSAs with a 300-fold excess of 
specific competitor, and near-complete competition occurred with a 300-fold excess of 
nonspecific competitor that contained no regulatory sequence (Figure 9b). A third set of 
competition assays for both FlgR and FlgR~P was attempted with higher protein 
concentrations and smaller amounts of unlabeled probe, but results were unreadable due to 
smearing that most likely resulted from an excess of glycerol as described above for CrdR. 
FlgR stocks were exhausted in this EMSA, but this assay should be repeated with an 
appropriate glycerol concentration when more FlgR can be purified.
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Figure 9. FlgR EMSAs with acxA-All probes, (a) FlgR and acxA-All EMSA/FIgR~P and acxA-All 
EMSA with competition test. First and last lanes: 2-log biotinylated DNA ladder (New England 
Biolabs). Reactions 1-5 contain 1 ng acxA-All* and reactions 2-5 contain 10 pg protein. This image 
represents the results of two replicate assays. Two apparent protein/acxA-All* complexes are present, 
with the less mobile complex dominant in figure 9a and the more mobile complex dominant in figure 
9b. (b) FlgR and acxA-All EMSA/FlgR~P and acxA-All EMSA with competition test. Leftmost 
lane: 2-log biotinylated DNA ladder. Reactions 6-10 contain 1 ng acxA-All* and reactions 7-10 contain 
5 pg protein, (c) SDS-PAGE of FlgR purification. Lanes: 1) Bio-Rad High Range Standards, 2) 
Elution 2, 3) Elution 3, 4) Elution 4. The pictured elution fractions were pooled and used in EMSAs. It 
is possible that FlgR was unintentionally co-purified with E. coli a54, as a band of the correct molecular 
weight is present.
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It is possible that these results indicate that FlgR binds to the upstream regulatory 
region of acxA independently, but more weakly than ArsR. However, according to the NCBI 
Conserved Domains Database, Helicobacter pylori FlgR lacks a known DNA-binding or 
response regulator effector domain. A study of FlgR and its flagellar regulon has identified 
this response regulator as an enhancer-independent a 54-binding transcriptional activator (30). 
In EMSAs, FlgR did not bind directly to probes generated from its known flagellar regulatory 
targets. However, FlgR was able to activate transcription of these target genes by interacting 
with both H. pylori and E. coli o54-RNA polymerase. A possible explanation for the results 
obtained in Figure 9 is that E. coli o54 associated with FlgR in the expression cultures and was 
unintentionally co-purified with FlgR. SDS-PAGE performed to evaluate the purity of the 
FlgR elution fractions shows a band that ran to the midpoint of the 45 kDa and 66 kDa bands 
of the ladder, which may be the E. coli a 54 subunit (Figure 9c). It is possible that the shift 
seen in figure 9a is actually a complex of the acxA-All probe and E. coli o54 that may or may 
not include FlgR. The acxA promoter region does not contain a good match to the consensus 
sequence for E. coli a 54 binding sites, so if  interaction of this sigma factor with acxA-All is 
responsible for the shift then the weak specificity that was observed is not surprising. 
Furthermore, if  this explanation is true, the results in Figure 9 are an artifact of protein 
purification and do not yield any information about in vivo regulation of acxA by FlgR in H. 
pylori. Performing additional EMSAs with acxA probes and purified E. coli a 54 could reveal 
whether the shift is an artifact due to interference from this sigma factor. If results are 
positive, FlgR could be expressed in rpoN- M l5 E.coli for use in future EMSAs to 
investigate the possibility that FlgR interacts directly with acxA despite its lack of an obvious 
DNA-binding motif.
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Helicobacter pylori FlgR activates transcription o f its flagellar regulon through 
interaction with o54 and in response to low environmental pH. However, acxA does not have a 
a 54 promoter, and its transcription is down-regulated in JlgS- H. pylori mutants in a pH- 
independent manner (31). This suggests that FlgR responds, via FlgS, to at least two types of 
signals which may lead to two distinct active states of FlgR with separate regulons. Because 
acxA has a housekeeping o80 promoter and because FlgR is already known to interact with 
one sigma factor, it would make sense to investigate potential interaction of FlgR and H. 
pylori o80 through co-immunoprecipitation or by performing an EMSA with acxA probes and 
both FlgR and H. pylori a 80 to look for a supershift. It is also possible that FlgR activates 
acxA expression by interacting directly with a currently unidentified transcription factor that 
binds the acxA promoter. If so, EMSAs including the acxA probe and FlgR along with this 
transcription factor would produce a supershift. A third possibility is that the activation of 
acxA by FlgR is indirect, and is mediated by one or more protein-protein and/or protein-DNA 
interactions.
HP1021 Mobility Shift Assay
The results in Figure 10 indicate that HP 1021 binds the promoter region of acxA 
whether or not it has been phosphorylated. (Although there is no evidence that HP 1021 is 
activated by phosphorylation, HP 1021 treated with phosphorylation buffer was used in the 
EMSA reactions in lanes 6-8 for control purposes.) This assay was performed in order to 
confirm previous results obtained with HP 1021 and acxA probes including the entire 
promoter region from strain 26695 (35). Pflock’s EMSA produced four shifted bands of 
various sizes, the middle two of which are visible in lanes 2-7 of Figure 10. (The smallest 
complex was very faint in Pflock’s assay and if present here would not be visible above the
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background. The largest complex, if it formed during the assay in Figure 10, did not run out 
of the wells.) It is possible that the high isoelectric point of HP 1021 (pi = 8.09) as predicted 
from its sequence caused low overall mobility in this assay, and that the complexes would be 
better visualized if  the pH of the gel and buffer was raised for the native PAGE portion of the 
EMSA. No specific competition was observed, so future experiments should include more 
tests for binding specificity o f HP 1021 to the acxA regulatory region. EMSAs should also be 
performed with the acxA-Up and acxA-Down probes to detect potential multiple HP 1021 
binding sites.
P ro te in  
5 0 0 x  a c x A -A ll 
50 0 x  EBNA DNA
HP1021
and acxA-All*
com plexes
H P1021 H P 1021-P
Unbound  
a ex A-AH *
+  —
■ V V “ ' : :
Figure 10. HP1021 and acxA-All EMSA with competition test. HP1021-P is HP 1021 that has been 
treated with the ArsR phosphorylation protocol for control purposes. There is no evidence that HP 1021 
can be phosphorylated. All reactions contain 1 ng acxA-All* and reactions 2-7 contain 10 pg protein. 
Leftmost lane: 2-log biotinylated DNA ladder (New England Biolabs). This image represents the results 
of two replicate assays.
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Concluding Remarks
These results, combined with previous studies o f ArsR and HP 1021, support direct 
regulation of acxABC  transcription by binding of ArsR, CrdR, and HP 1021 to the acxA 
upstream regulatory region (37, 35). Furthermore, EMSA results for ArsR suggest that the 
degree of repression o f acxA transcription by this response regulator may be modulated by 
binding o f ArsR to four distinct sites in the acxA upstream regulatory region. EMSA results 
for CrdR suggest that this response regulator interacts directly with the acxA upstream 
regulatory region in at least two different conformations depending on the phosphorylation 
state of CrdR. These results demonstrate the importance of the acxABC  operon as a model for 
multilayered gene regulation by a variety o f mechanisms at a single locus.
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Future Directions
Optimization of the Response Regulator Purification and 
EMSA Protocols
Obtaining Clearer and More Consistent EMSA Results
O f the three response regulators that bind directly to the acxA upstream regulatory 
region, the EMSA protocol for CrdR requires the most optimization. Despite being the only 
published EMSA protocol for CrdR, Waidner’s combined phosphorylation and binding 
protocol produced no results in our lab. It is possible that this is due to a lack of a DNA 
carrier, which was not mentioned in Waidner’s methods but may have been omitted in error 
(27). For optimization purposes, one could re-try this protocol and add poly dl-dC to the 
same concentration specified by the ArsR protocol. First, however, more CrdR EMSAs with 
the ArsR and Thermo base protocols should be attempted with an appropriate amount of 
glycerol in the reaction. In the successful ArsR EMSAs shown in Figures 3, 5, and 6, the 
concentration of glycerol in the binding reactions after addition of the loading buffer was 9- 
12% by volume. A study o f the effect o f glycerol on acrylamide gel electrophoresis indicates 
that the clearest results may be obtained when the glycerol concentration in a DNA sample to 
be electrophoresed is twice the concentration o f acrylamide in the gel, which would set the 
ideal glycerol concentration for the EMSA samples in this thesis work at 12% (45). However, 
the samples in lanes 2-5 of Figure 8 were at least 20% glycerol. The excess glycerol stems 
from the relatively low CrdR concentration has been obtained in every purification performed 
so far. Since all protein stocks have at least 10% glycerol added for preservation, the volume 
of a low-concentration protein stock that is added to a binding reaction will be larger and will 
therefore contain more glycerol than that o f a more concentrated protein stock. Smearing of
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the CrdR binding reactions could be minimized by omitting glycerol from the binding buffer 
and by obtaining more concentrated CrdR.
The ArsR EMSAs performed in this thesis work produced consistent shifts, but 
inconsistent results in tests for specific binding. In a more recent EMSA performed in our 
lab, increasing the amount of labeled acxA-All probe to 14 frnol per reaction allowed for 
visualization of minor bands produced by competition with unlabeled probe (46). It may be 
that the use of more labeled probe in each EMSA reaction is all that is necessary to visualize 
all of the ArsR/probe complexes and free probe bands that are present on the blot. It is also 
possible that the difficulty of demonstrating binding specificity o f ArsR to acxA-All is 
atypical, and that specific binding of ArsR to probes used in future experiments may be 
demonstrated as easily as it was for the acxA-Up and acxA-Down probes. If binding 
specificity o f ArsR cannot be demonstrated reliably in future acxA EMSAs even after the 
amount of labeled probe is increased, then optimization of the binding buffer and/or reaction 
conditions may be required.
HP 1021 interacts with the acxA-all probe to produce an extraordinarily large shift 
(Figure 10). In order to perform EMSAs with HP 1021 to locate the binding site(s) of this 
response regulator in the acxA upstream regulatory region, it will first be necessary to 
optimize the HP 1021 EMSA protocol so that all four potential HP 1021 /acxA-All complexes, 
as seen in Pflock’s study, may be visualized. This could be accomplished by using a larger 
gel apparatus, but this solution requires development of a new blot protocol (the blotting tank 
used for the experiments described in this thesis only accommodates mini-gels, which are 8 
cm wide and 6 cm high excluding the wells) and increasing the size of the blots would add 
considerable expense due to increased consumption o f chemiluminescent EMSA reagents 
(Thermo). A potential work-around involves electrophoresing the HP 1021 binding reactions
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in a large gel electrophoresis cell until the distance between the largest known HP 1021/probe 
complex and the free probe is slightly less than 8 cm. A 6 cm wide and 8 cm high section of 
the gel containing the electrophoresed EMSA reactions is excised, rotated 90°, and placed in 
the tank-blotting apparatus. The EMSA would be completed as described in the methods 
section. This method would require some optimization, but effectively adds 2 cm vertical 
distance to each lane, which may be enough additional room for all of the HP 1021/probe 
complexes to appear on the blot.
An alternate approach to optimization of the HP 1021 EMSAs is to increase the 
mobility o f the HP 1021 /acxA-All complexes. The isoelectric point of HP 1021 as predicted 
from its amino acid sequence is 8.09, and the pH of the running buffer and the gel used for 
electrophoresis o f the HP 1021 binding reactions was 8.3. The HP 1021 EMSA protocol was 
developed with the assumption that the probe, being negatively charged and more than seven 
times the molecular weight of HP 1021, would “carry” bound HP 1021 through the gel. 
However, the results o f the EMSA shown in Figure 10 indicate that the effect of the IEP of 
HP 1021 on the mobility o f these complexes may be greater than expected. In a Blue Native- 
PAGE assay performed with a gel and running buffer at pH = 9.0, HP 1021 migrated 
approximately 3 cm in 3.5 hours (data not shown). Performing the electrophoresis portion of 
the HP1021 EMSA at pH<9 may therefore increase the mobility of the HP1021/probe 
complexes so that all o f them appear on an 8 x 6 cm mini-blot.
Increasing Response Regulator Purification Yields
The current CrdR expression protocol developed in this study produces low 
concentrations o f soluble CrdR, limiting downstream applications and leading to unreliable 
and unclear EMSA results. Though it is a cytoplasmic protein, H. pylori CrdR is mostly
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insoluble when extracted after being overexpressed in E. coli, most likely due to the 
formation of inclusion bodies. Soluble CrdR can only be purified from E. coli cultures with 
expression levels that are too low to yield an adequate CrdR concentration after purification. 
More concentrated CrdR stocks may be obtained by cloning just the CrdR DNA-binding 
domain (DBD), or by creating a CrdR-MBP (maltose-binding protein) fusion. Steps have 
already been taken in our lab to clone the CrdR-DBD, though it has not yet been purified. In 
previous studies in which protein solubility was a concern, individual domains have been less 
likely to form inclusion bodies than full-length proteins, so it is possible that CrdR-DBD will 
remain soluble when expressed in larger amounts than full-length CrdR (8).
Though EMSAs performed with CrdR-DBD could yield limited information about 
the locations of CrdR binding sites, full-length CrdR is necessary to obtain the most useful 
data about binding mechanisms and networking between H. pylori’s TCST systems. Since 
phosphorylation occurs on the receiver domain of CrdR, CrdR-DBD could not be used for 
further study o f the effect o f phosphorylation status on the binding of CrdR to the upstream 
regulatory region of acxA (Figure 8). Also, it is possible that direct interactions occur 
between CrdR and other regulatory proteins, and if  so it is likely that these interactions 
involve the CrdR receiver domain. Fusion with E. coli maltose-binding protein is known to 
promote solubility o f recombinant proteins when they are expressed in E. coli, and the bond 
between the protein of interest and MBP can be cleaved after purification to avoid 
interference of MBP in downstream experiments (47). Creation of a CrdR-MBP fusion may 
allow purification of adequate concentrations of full-length CrdR for future experiments. If 
necessary, this technique could be applied towards obtaining more concentrated stocks of the 
other response regulators as well.
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Investigation of FlgR Protein-Protein Interactions
As discussed in the Results, it is possible that recombinant H. pylori FlgR associated 
with an E. coli transcription factor during purification, and that nonspecific binding of this E. 
coli protein to the acxA-All probe caused the shift observed in the EMSA (Figure 9).
Because the ability to purify FlgR without contamination by other transcription factors is 
important for future experiments, it may be helpful to know which E. coli protein is being co­
purified with FlgR. Recombinant FlgR could then be expressed in M l5 E. coli that cannot 
express the contaminant assuming that it is not an essential gene. Since FlgR activates 
transcription by interacting with H. pylori a 54 RNA polymerase holoenzyme and is known to 
associate with E. coli cr54 in vitro, one possible solution is to create a rpoN- M l5 E. coli 
mutant and express recombinant H. pylori FlgR in this strain (30). Flowever, this will only 
work if FlgR associates with a 54 and no other E. coli transcription factors during purification.
Since a large number of genes in the FlgR regulon do not have a54 promoters, it is 
possible that FlgR interacts with other H.pylori transcription factors as well. It seems likely 
that if  the E. coli DNA-binding protein co-purified with FlgR was not E. coli a 54, it was the 
E. coli homolog o f another H. pylori protein with which FlgR interacts with in vivo. A yeast 
two-hybrid screen performed with an expression vector carrying H. pylori FlgR as the bait 
and a library o f prey plasmids constructed from H. pylori total cDNA could reveal 
interactions between FlgR and other H. pylori proteins. However, this assay does not allow 
for FlgR phosphorylation, which may be critical to its protein-protein interactions. Since H. 
pylori is only known to express 12 transcription factors including FlgR and sigma factors, 
cloning and adding FLAG-tags to these transcription factors and performing co- 
immunoprecipitation with FlgR would be feasible. (The ability to express and purify every H.
pylori transcription factor would also be very useful in investigation o f regulatory networks.)
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M l 5 E. coli mutants lacking orthologs o f the H. pylori transcription factors(s) that associated 
with FlgR could then be used for FlgR expression. If FlgR associates with an essential 
protein, it may be possible to adjust the purification protocol to disrupt this interaction.
Identification of Binding Sites for ArsR, CrdR, and HP1021
Based the EMSA results shown in figures 3, 4, and 6 ,1 hypothesize that there are at 
least four ArsR binding sites in the upstream regulatory region of acxABC ; two upstream and 
two downstream of the -35 site of the promoter. The CrdR EMSA results obtained in this 
study indicate that CrdR interacts with at least one binding site in the acxA regulatory region 
(Figure 8). I also hypothesize that there are multiple HP 1021 binding sites within this 
regulatory sequence based on the four HP1021/probe complexes observed in Pflock’s EMSA 
(35). Locating the binding sites for all o f these response regulators is the logical next step 
toward characterizing the mechanisms by which ArsR, CrdR, and HP 1021 regulate 
transcription of acxABC. This could be accomplished with DNA footprinting, but if  it is 
necessary to avoid the use o f radioactive reagents then binding sites could be located with 
additional chemiluminescent EMSAs. Waidner was able to locate the CrdR binding site in 
the upstream regulatory region of crdA by performing EMSAs with a series of DNA probes 
containing different parts of this regulatory sequence (27). A similar set o f probes could be 
constructed for the acxA upstream regulatory region and used in EMSAs with ArsR, CrdR, 
and HP 1021 (Figure 11).
Investigation of TCST Networking in Regulation of acxABC
The degree o f overlap between the binding sites of ArsR, CrdR, and HP 1021 in the 
acxABC upstream regulatory region will be fundamental for building models of competition
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Figure 11. Proposed method for location of response regulator binding sites. The proposed acxA- 
Upl probe ends 23 bp upstream of the -35 site, and excludes the inverted repeats (marked with a dashed 
underline). If a response regulator binds specifically to acxA-Up and not acxA-Upl, then these inverted 
repeats are likely to be the binding site. New incrementally spaced acxA probes could be constructed 
and used in EMSAs, with the probes being moved upstream 20 bp at a time until all of the response 
regulator binding sites in the acxABC upstream regulatory region have been identified. A series of 
incrementally spaced acxA-Down probes could be created and used in EMSAs in the same manner. The 
acxA-Downl probe could be used to determine the significance of the -10 to -35 region of the acxA 
promoter in direct regulation via TCST, and the acxA-Down2 probe could be used to test for binding of 
response regulators to the -10 site of the acxA promoter.
between these TCST response regulators for transcriptional control of acxABC. However, it 
is also possible that two or more different response regulators may act on the acxA upstream 
regulatory region simultaneously. A combination of modified EMSAs and co- 
immunoprecipitation assays could be used to detect protein-protein interactions that may 
occur between TCST response regulators while they are bound to the acxA upstream 
regulatory region. As noted above, these techniques will be particularly important in 
identifying whether or not FlgR interacts directly with another transcription factor to activate 
acxA transcription. Because FlgR is already known to interact with at least one H. pylori 
sigma factor and acxA has a a 80 promoter, I hypothesize that FlgR may be an activator of H. 
pylori a 80 as well as o54 (30). Once recombinant H. pylori a 80 has been cloned and purified as 
described above, a series o f EMSAs could be performed with FlgR and o80 in the same
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binding reaction. If a binding reaction containing both FlgR and o80 with the acxA-All probe 
produces a larger shift than the same reaction without FlgR, this would suggest that FlgR 
interacts directly with o80 to initiate acxA transcription. This test could also be used to detect 
interaction of FlgR with any of the other H. pylori transcription factors at the acxA regulatory 
region.
Similar techniques could be applied to look for direct interactions between any o f the
H. pylori response regulators. If  separate binding sites for two different response regulators 
are found, then an EMSA could be performed with both response regulators and a DNA 
probe including both binding sites in a single reaction. When compared with results for 
binding reactions containing this probe and only one of the proteins, a supershift would 
indicate simultaneous binding of both response regulators to the probe. Co- 
immunoprecipitation could then be used to investigate whether or not these response 
regulators may interact directly with each other while bound to DNA upstream of acxABC. 
The possibility o f direct physical interaction between members of different TCST systems is 
especially interesting in the case of the acid response. ArsRS, FlgS, and HP 1021 are all 
known to respond to low environmental pH, and CrdS is required for survival of H. pylori in 
acidic conditions (25). The integration of the environmental acidity signal by the acid- 
responsive TCST systems is not yet fully understood. As the regulatory target of all three 
TCST response regulators and HP 1021, acxABC  may be an ideal model for study of the 
global transcriptional response of H. pylori to acid exposure.
Investigation of Environmental Influences on acxABC Expression
The expression level o f acxA is altered when any one o f H.pylorV s two-component
signal transduction systems is deleted or made non-functional by mutation, and also has been
shown to change with changes in environmental pH levels. However, acidity cannot be the
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only environmental signal that affects acxA expression, because CrdRS and HP 1021 do not 
respond to changes in pH. Additionally, the acxABC operon is a member of the pH- 
independent regulon of FlgS, and the signal(s) sensed by FlgS in addition to acidification of 
the cytoplasm are unknown (31).
The relative change in expression of acxABC in response to various chemical 
environmental signals can be measured via qRT-PCR. In this assay, H. pylori is grown 
overnight in liquid culture, exposed to an environmental signal suspected to alter expression 
of acxA, and then cells are harvested for RNA extraction and subsequent qRT-PCR with 
acxA primers. Potential environmental signals for acxA regulation include acidity, copper, 
oxidative stress, acetone, acetoacetate, and p-hydroxybutyrate: Previous results suggest that 
the repression of acxABC  in acidic conditions may be gradual, so a range of pH levels should 
be included in this assay. Copper and oxidative stress are included because CrdS is known to 
sense increased environmental Cu2+ concentration and is a potential oxidative stress sensor, 
but the effect o f these two environmental conditions on acxABC  expression has not yet been 
measured (27). Hydrogen peroxide could be added to the H. pylori growth media to simulate 
the release of reactive oxygen species by the host immune system. Finally, though no sensor 
kinase is currently known to sense ketone bodies, it would be an advantage for H. pylori to 
express acetone carboxylase only when enough acetone is available to compensate for the 
energy used to construct this enzyme. Therefore, one o f the signals sensed by TCST systems 
that regulate acxABC  expression may be acetone or one of the other two ketone bodies that 
are produced with acetone; acetoacetate and P-hydroxybutyrate. Acetoacetate decomposes 
spontaneously to acetone above room temperature and therefore cannot be used in this 
experiment, but acetone and p-hydroxybutyrate could be added separately to H. pylori 
cultures to test their individual effects on acxABC expression.
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If environmental signals that activate or repress acxA expression in addition to acidity 
are identified through qRT-PCR, then the next step is to identify which TCST systems 
regulate acxA in response to the newly discovered signals. This necessitates the creation of 
crdS-,flgS-, and arsS- H. pylori mutants for use in additional qRT-PCR assays. (A hp!021- 
mutant could be created as well, but due to the small-colony phenotype it may not be feasible 
to grow this mutant in liquid culture as is necessary for this assay.) If any one of these mutant 
strains has lost its ability to alter expression of acxA in response to one of the previously 
identified signals, then it is likely that the signal in question is detected by the sensor kinase 
that is deleted in this strain.
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